ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SNG Synairgen Plc

4.36
-0.395 (-8.31%)
Last Updated: 08:44:49
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Synairgen Plc LSE:SNG London Ordinary Share GB00B0381Z20 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.395 -8.31% 4.36 4.35 4.69 4.75 4.36 4.75 139,295 08:44:49
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -17.65M -0.0876 -0.54 9.58M
Synairgen Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SNG. The last closing price for Synairgen was 4.76p. Over the last year, Synairgen shares have traded in a share price range of 3.65p to 10.62p.

Synairgen currently has 201,374,975 shares in issue. The market capitalisation of Synairgen is £9.58 million. Synairgen has a price to earnings ratio (PE ratio) of -0.54.

Synairgen Share Discussion Threads

Showing 22076 to 22100 of 99175 messages
Chat Pages: Latest  895  894  893  892  891  890  889  888  887  886  885  884  Older
DateSubjectAuthorDiscuss
17/8/2020
17:11
market makers waiting for sellers
stockhunters
17/8/2020
16:30
Worth cutting and pasting the Finncap report (Finncap.com; available for free to all registered users) section on Synairgen's valuation, as it is evident that the assumptions used to reach their £3.60 current valuation will be blown out of the water by regulatory approval and early sales into the market. Based on adjusting for these two factors, valuation would go above £10 on any announcement of approval and indication of sales.

Extract below:

'We value SNG001 (for COVID-19) at c.£478m (320p per share) on a risk-adjusted basis, using the following assumptions in our DCF, which follows a typical sales cycle with product launching in 2-3 years’ time and peak sales achieved in 5 years post-launch. As indicated in previous reports, this is very simplistic, given the emergency nature of the current COVID crisis:

£1.25bn peak sales. Given the size of the market, peak sales could be substantially higher and the sales curve could peak much sooner than our model indicates, particularly if governments or national agencies buy the product ahead of the winter 2020 flu season. The rNPV would also be substantially higher if governments see SNG001 as a broad spectrum antiviral treatment that should be stockpiled for future pandemics or used routinely to treat seasonal winter infections (influenza) where hospital pneumonia is a substantial issue.

50% probability of successfully reaching the market. Given the clear need for a treatment, sales and marketing expenses would be minimal.

Discount rate of 10%.

We increase our target price from 120p to 360p based on a sum-of-the parts DCF (Figure 1), which also includes c.38p for SNG001 (COPD) and the economic interest that Synairgen has in Pharmaxis’s LOXL2 programme.'

bignads
17/8/2020
16:28
Co did say further analysis of the data over coming WEEKS but move rapidly towards regulatory approval.Must be mid to end of this exercise.
allin
17/8/2020
16:26
Very small hat, or VERY big head ??



🤔

frosty sparks
17/8/2020
16:24
Nice reversal, it all bodes very well.
festario
17/8/2020
14:51
Strongbuy - do you end *every* post with rockets? They might have more impact if you saved them for when they were justified?
sloppyjoe2
17/8/2020
14:46
Anyone see anything mentioned ??🚀🚀
strongbuy
17/8/2020
14:01
Disappointing price action - and volume - today. Right now doesn't look like a stock where big news is about to drop...
sloppyjoe2
Chat Pages: Latest  895  894  893  892  891  890  889  888  887  886  885  884  Older

Your Recent History

Delayed Upgrade Clock